Repository logo
  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Universidad Panamericana
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • Researchers
  • Statistics
  • Feedback
  • English
  • Deutsch
  • Español
  • Français
  1. Home
  2. CRIS
  3. Publications
  4. Tumor híbrido de la vaina del nervio periférico, con componentes de schwannoma mixoide, schwannoma tipo neuroblastoma y perineuroma
 
  • Details
Options

Tumor híbrido de la vaina del nervio periférico, con componentes de schwannoma mixoide, schwannoma tipo neuroblastoma y perineuroma

Journal
Gaceta Mexicana de Oncología
ISSN
2565-005X
Date Issued
2021
Author(s)
Macari-Jorge, Andrés
Ortíz Hidalgo, Carlos Federico  
Facultad de Ciencias de la Salud - CampCM  
Type
Resource Types::text::journal::journal article
DOI
10.24875/j.gamo.20000112
URL
https://scripta.up.edu.mx/handle/123456789/2162
Abstract
A 43-year-old female presented with an oval eccentric solid lesion fixed to the submandibular gland. The tumor was composed of bland spindle cells embedded in a myxoid stroma with focal areas showing large cellular rosettes. Both areas were positive for S100 protein and glial fibrillary acidic protein. Some of the elongated spindle cells were also positive for epithelial membrane antigen, and glucose transporter 1, indicating perineurial cell differentiation. A diagnosis of hybrid tumor with myxoid schwannoma, neuroblastoma-like schwannoma and perineuroma components was rendered. The lesion was resected completely and has not recurred after eight months of resection. ©Gaceta Mexicana de Oncología
Subjects

Peripheral nerve shea...

Hybrid tumors

Schwannoma

Perineuroma

Immunohistochemistry


Copyright 2024 Universidad Panamericana
Términos y condiciones | Política de privacidad | Reglamento General

Built with DSpace-CRIS software - Extension maintained and optimized by - Hosting & support SCImago Lab

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback